LXEO Lexeo Therapeutics PE ratio, current and historical analysis
As of Mar 19, 2025, the Lexeo Therapeutics stock's PE ratio is 0.17. This results from the current EPS of $17.54 and stock price of $3.04.
LXEO PE ratio history
Lexeo Therapeutics PE ratio by year
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2023 | N/A | N/A | $13.42 | -$12.4 |
| 2022 | N/A | N/A | N/A | -$36.36 |
| 2021 | N/A | N/A | N/A | -$32.6 |
Lexeo Therapeutics PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Sep 2024 | 0.52 | -80.3% | $9.04 | $17.54 |
| Jun 2024 | 2.64 | N/A | $16.04 | $6.07 |
| Mar 2024 | N/A | N/A | $15.68 | -$1.59 |
| Dec 2023 | N/A | N/A | $13.42 | -$12.4 |
| Sep 2023 | N/A | N/A | N/A | -$41.1 |
| Jun 2023 | N/A | N/A | N/A | -$39.12 |
| Mar 2023 | N/A | N/A | N/A | -$40.05 |
| Dec 2022 | N/A | N/A | N/A | -$36.36 |
| Sep 2022 | N/A | N/A | N/A | N/A |
| Jun 2022 | N/A | N/A | N/A | N/A |
| Dec 2021 | N/A | N/A | N/A | -$32.6 |
LXEO average PE ratio chart
LXEO PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| LXEO Lexeo Therapeutics Inc. | 0.16 | $91.26M |
| NTLA Intellia Therapeutics Inc | N/A | $909.92M |
| BLUE bluebird bio Inc | N/A | $37.04M |
| CRSP CRISPR Therapeutics AG | N/A | $3.55B |
| EDIT Editas Medicine Inc | N/A | $112.02M |
| QURE uniQure NV | N/A | $740.85M |
| RGNX REGENXBIO Inc | N/A | $410.46M |
| SGMO Sangamo Therapeutics Inc | N/A | $189.9M |
| ADVM Adverum Biotechnologies Inc | N/A | $116.7M |
| BEAM Beam Therapeutics Inc | N/A | $1.92B |
| VERV Verve Therapeutics Inc | N/A | $481.27M |
Frequently asked questions
What is Lexeo Therapeutics's PE ratio?
As of Mar 19, 2025, LXEO stock has a price to earnings ratio of 0.17.
Why is Lexeo Therapeutics's PE ratio so low?
LXEO's stock price is trading at a lower multiple of earnings, which is why its PE ratio of 0.17 is considered low.
How is LXEO's PE ratio calculated (Lexeo Therapeutics PE ratio formula)?
You can calculate the PE ratio by dividing the most recent stock price by the trailing twelve months EPS. As of today (Mar 19, 2025), Lexeo Therapeutics's stock price is $3.04. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $17.54. Therefore, Lexeo Therapeutics's P/E ratio for today is 0.17. PE RATIO(0.17) = STOCK PRICE($3.04) / TTM EPS($17.54)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.